VKTX: Viking Therapeutics Inc. Stocks News on July 12, 2025

Why This Weight Loss Drug Company's Stock Surged Today

VKTX

Motley Fool

16 days ago

Why This Weight Loss Drug Company's Stock Surged Today

Viking commences Phase III clinical programme of VK2735 for obesity

VKTX

Clinical Trials Arena

16 days ago

Viking commences Phase III clinical programme of VK2735 for obesity

VKTX

Zacks

16 days ago

VKTX Initiates Phase 3 Study on Obesity Candidate VK2735

VKTX

Motley Fool

16 days ago

3 Growth Stocks I'm Loading Up On

Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity

VKTX

Investor's Business Daily

17 days ago

Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity

VKTX

MT Newswires

17 days ago

Viking Therapeutics Begins Phase 3 Trial of Dual Agonist VK2735 in Obesity

VKTX

PR Newswire

17 days ago

Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

VKTX

Motley Fool

21 days ago

2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts

VKTX

Zacks

22 days ago

Viking Therapeutics, Inc. (VKTX) Dips More Than Broader Market: What You Should Know

Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.

VKTX

Motley Fool

24 days ago

Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.

VKTX

Zacks

a month ago

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks?

VKTX

Motley Fool

a month ago

Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks?

VKTX

Insider Monkey

a month ago

Viking Therapeutics (VKTX) Rises on Expected Developments

VKTX

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Stock Drops Despite Market Gains: Important Facts to Note

VKTX

Simply Wall St.

a month ago

We're Hopeful That Viking Therapeutics (NASDAQ:VKTX) Will Use Its Cash Wisely

VKTX

Insider Monkey

a month ago

Was Jim Cramer Right to Favor Another Stock Over Viking Therapeutics (VKTX)?

1 Stock Down 34% This Year to Buy and Hold

VKTX

Motley Fool

a month ago

1 Stock Down 34% This Year to Buy and Hold

VKTX

Zacks

a month ago

Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know

Could Viking Therapeutics Become the Next Eli Lilly?

VKTX

Motley Fool

a month ago

Could Viking Therapeutics Become the Next Eli Lilly?

VKTX

Motley Fool

a month ago

3 Best Growth Stocks to Buy in June

VKTX

Zacks

a month ago

Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views?

Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?

VKTX

Zacks

a month ago

Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock Has More Upside?

Better Weight Loss Stock: Amgen or Viking Therapeutics?

VKTX

Motley Fool

2 months ago

Better Weight Loss Stock: Amgen or Viking Therapeutics?

Why Viking Therapeutics Stock Bumped 3% Higher Today

VKTX

Motley Fool

2 months ago

Why Viking Therapeutics Stock Bumped 3% Higher Today

Novo Nordisk Sheds 3% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price

VKTX

Investor's Business Daily

2 months ago

Novo Nordisk Sheds 3% After Ousting CEO As Eli Lilly Rivalry Slams Stock Price

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years

VKTX

Motley Fool

2 months ago

2 Monster Stocks in the Making to Buy Now and Hold for 10 Years

VKTX

Motley Fool

2 months ago

3 Monster Stocks in the Making

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April

VKTX

Motley Fool

2 months ago

Why Viking Therapeutics Stock Surged Nearly 20% Higher in April

Why Viking Therapeutics Stock Was Victorious This Week

VKTX

Motley Fool

2 months ago

Why Viking Therapeutics Stock Was Victorious This Week

VKTX

Simply Wall St.

2 months ago

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss of US$46 Million in Q1 2025

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

VKTX

Motley Fool

2 months ago

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

VKTX

Motley Fool

2 months ago

Is Novo Nordisk Stock a Buy?

Where Will Viking Therapeutics Be in 3 Years?

VKTX

Motley Fool

2 months ago

Where Will Viking Therapeutics Be in 3 Years?

1 Beaten-Down Stock to Buy and Hold for 10 Years

VKTX

Motley Fool

2 months ago

1 Beaten-Down Stock to Buy and Hold for 10 Years

Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

VKTX

Motley Fool

2 months ago

Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain

VKTX

Motley Fool

2 months ago

Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain

Why Viking Therapeutics Stock Popped Again Today

VKTX

Motley Fool

2 months ago

Why Viking Therapeutics Stock Popped Again Today

VKTX

MT Newswires

2 months ago

Cantor Fitzgerald Initiates Viking Therapeutics at Overweight With $104 Price Target

Why Viking Therapeutics Stock Popped Today

VKTX

Motley Fool

2 months ago

Why Viking Therapeutics Stock Popped Today

VKTX

MT Newswires

3 months ago

Truist Securities Cuts Viking Therapeutics Price Target to $75 From $95, Maintains Buy Rating

VKTX

Simply Wall St.

3 months ago

Viking Therapeutics (NasdaqCM:VKTX) Reports Increased Net Loss for Q1 2025

VKTX

MT Newswires

3 months ago

B. Riley Adjusts Price Target on Viking Therapeutics to $85 From $96, Maintains Buy Rating

VKTX

Thomson Reuters StreetEvents

3 months ago

Q1 2025 Viking Therapeutics Inc Earnings Call

Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips

VKTX

Zacks

3 months ago

Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips

VKTX

GuruFocus.com

3 months ago

Viking Therapeutics Inc (VKTX) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Rising ...

VKTX

Insider Monkey

3 months ago

Viking Therapeutics, Inc. (VKTX): Among Takeover Rumors Hedge Funds Are Buying

VKTX

MT Newswires

3 months ago

Viking Therapeutics Q1 Loss Widens; Shares Drop After Hours

VKTX

MT Newswires

3 months ago

Oppenheimer Cuts Price Target on Viking Therapeutics to $100 From $164, Keeps Outperform Rating

VKTX

Zacks

3 months ago

Is Viking Therapeutics (VKTX) a Buy as Wall Street Analysts Look Optimistic?

LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study

VKTX

Zacks

3 months ago

LLY Stock Up as Oral GLP-1 Pill Meets Goals in First Phase III Study

Viking Therapeutics to Report Q1 Earnings: What's in the Cards?

VKTX

Zacks

3 months ago

Viking Therapeutics to Report Q1 Earnings: What's in the Cards?

VKTX

Simply Wall St.

3 months ago

Viking Therapeutics (NasdaqCM:VKTX) Completes Enrollment For Phase 2 Trial Of VK2735

H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data

VKTX

TipRanks

3 months ago

H.C. Wainwright still expects Viking to ‘differentiate’ after Lilly data

Eli Lilly jumps as results from weight-loss pill study rival competitor’s

VKTX

TipRanks

3 months ago

Eli Lilly jumps as results from weight-loss pill study rival competitor’s

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

VKTX

TipRanks

3 months ago

JPMorgan says Lilly data ‘highly favorable’ for Structure Therapeutics

VKTX

Zacks

3 months ago

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill

VKTX

Investor's Business Daily

3 months ago

Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

VKTX

Motley Fool

3 months ago

Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide

2 Stocks Down by 25% or More This Year to Buy and Hold

VKTX

Motley Fool

3 months ago

2 Stocks Down by 25% or More This Year to Buy and Hold

Eli Lilly Rockets 12% After Solidifying Its Lead For A Weight-Loss Pill

VKTX

Investor's Business Daily

3 months ago

Eli Lilly Rockets 12% After Solidifying Its Lead For A Weight-Loss Pill

Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025

VKTX

PR Newswire

3 months ago

Viking Therapeutics to Report Financial Results for First Quarter 2025 on April 23, 2025

Pfizer Halts Obesity Pill Development Amid Safety Concerns

VKTX

Zacks

3 months ago

Pfizer Halts Obesity Pill Development Amid Safety Concerns

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill

VKTX

TipRanks

3 months ago

Smaller obesity drugmakers jump after Pfizer scraps weight-loss pill

Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?

VKTX

Motley Fool

3 months ago

Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?

VKTX

Zacks

3 months ago

NVO, LLY, GPCR & VKTX Stocks Gain Following PFE's Obesity Study Setback

VKTX

Insider Monkey

3 months ago

Why Viking Therapeutics, Inc. (VKTX) Skyrocketed On Monday?

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

VKTX

Motley Fool

3 months ago

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

3 Magnificent Stocks That Could Double or More by 2030

VKTX

Motley Fool

3 months ago

3 Magnificent Stocks That Could Double or More by 2030

Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years?

VKTX

Motley Fool

3 months ago

Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years?

VKTX

MT Newswires

3 months ago

Goldman Sachs Initiates Viking Therapeutics With Neutral Rating, $30 Price Target

The Smartest Biotech Stocks to Buy With $50

VKTX

Motley Fool

3 months ago

The Smartest Biotech Stocks to Buy With $50

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?

VKTX

Motley Fool

3 months ago

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now?

VKTX

Zacks

3 months ago

Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade

VKTX

Simply Wall St.

3 months ago

Viking Therapeutics (NasdaqCM:VKTX) Seals Manufacturing Deal as Stock Declines 11% Over The Past Month

VKTX

Zacks

3 months ago

Brokers Suggest Investing in Viking Therapeutics (VKTX): Read This Before Placing a Bet

VKTX

Zacks

3 months ago

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study

VKTX

Investor's Business Daily

4 months ago

Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

VKTX

PR Newswire

4 months ago

Viking Therapeutics Announces Completion of Enrollment in Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity

VKTX

Zacks

4 months ago

Viking Therapeutics, Inc. (VKTX) Rises But Trails Market: What Investors Should Know

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

VKTX

Motley Fool

4 months ago

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly

1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street

VKTX

Motley Fool

4 months ago

1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?

VKTX

Motley Fool

4 months ago

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?

VKTX

Simply Wall St.

4 months ago

Viking Therapeutics (NasdaqCM:VKTX) Soars 10% With CordenPharma Manufacturing Agreement

VKTX

Zacks

4 months ago

Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?

VKTX

Zacks

4 months ago

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?

VKTX

Zacks

4 months ago

How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma

VKTX

Insider Monkey

4 months ago

Why Viking Therapeutics Inc. (VKTX) Is Skyrocketing Today?

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

VKTX

Motley Fool

4 months ago

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped

B. Riley sees two key positives in Viking manufacturing agreement

VKTX

TipRanks

4 months ago

B. Riley sees two key positives in Viking manufacturing agreement

VKTX

Zacks

4 months ago

VKTX Inks Manufacturing Deal With CordenPharma for Obesity Drug Supply

Viking strikes $150m deal to secure supply of obesity drug

VKTX

Pharmaceutical Technology

4 months ago

Viking strikes $150m deal to secure supply of obesity drug

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.

VKTX

Investor's Business Daily

4 months ago

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled.

Stellantis, Tesla, Viking Therapeutics: Market Minute

VKTX

Yahoo Finance Video

4 months ago

Stellantis, Tesla, Viking Therapeutics: Market Minute

Viking Therapeutics closer to bringing its Ozempic competitor to market

VKTX

Quartz

4 months ago

Viking Therapeutics closer to bringing its Ozempic competitor to market

VKTX

MT Newswires

4 months ago

Update: Viking Therapeutics Shares Fall After Manufacturing Deal With CordenPharma

H.C. Wainwright says Novo results support Viking obesity potential

VKTX

TipRanks

4 months ago

H.C. Wainwright says Novo results support Viking obesity potential

VKTX

Zacks

4 months ago

Wall Street Bulls Look Optimistic About Viking Therapeutics (VKTX): Should You Buy?

VKTX

MT Newswires

4 months ago

Viking Therapeutics Signs Manufacturing Deal With CordenPharma for Obesity Program

Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735

VKTX

PR Newswire

4 months ago

Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735

This Weight Loss Stock Could Skyrocket by 462%, According to Wall Street

VKTX

Motley Fool

4 months ago

Latest Viking Therapeutics Inc. (VKTX) News on July 12, 2025

Share on Social Networks: